UOC
DMTK

UBS O'Connor’s DermTech, Inc. Common Stock DMTK Stock Holding History

UBS O'Connor’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,413,334
Closed -$5.6M – 861
2022
Q3 		$5.6M Sell
1,413,334
-1,536,666
-52% -$9.45M 0.06% 192
2022
Q2 		$16.3M Buy
2,950,000
+1,658,156
+128% +$13.6M 0.17% 68
2022
Q1 		$19M Buy
1,291,844
+191,844
+17% +$2.57M 0.21% 57
2021
Q4 		$17.4M Buy
1,100,000
+1,000,000
+1,000% +$24M 0.17% 54
2021
Q3 		$3.21M Buy
+100,000
New +$3.51M 0.03% 412

Other funds holding DMTK

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EP
EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS O'Connor's DMTK Position: Q4 2022 in Review

UBS O'Connor sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2022, closing a stake of 1,413,334 shares — an estimated $5.6M sold.

UBS O'Connor first reported a position in DMTK in Q3 2021 and held it in 5 quarters. The position peaked at $19M in Q1 2022. 94 funds tracked by Wall St. Rank hold DMTK as of Q4 2022.

  • UBS O'Connor reported no remaining DermTech, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • UBS O'Connor sold 1,413,334 DermTech, Inc. Common Stock shares in Q4 2022, an estimated $5.6M.
  • UBS O'Connor first reported a position in DermTech, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
  • UBS O'Connor's DermTech, Inc. Common Stock position peaked at $19M in Q1 2022.
  • 94 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.